Plain-English translation of NCT03987308 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new medication called that is delivered continuously under the skin using a small pump device. Researchers want to see if this new treatment works as well as or better than the standard insulin pump therapy that many newly diagnosed type 2 diabetes patients receive. Both treatments will be compared over 8 weeks to see which one better controls blood sugar and how safe each option is.
Type 2 diabetes requires careful blood sugar management, and while insulin pumps work well, doctors are looking for other effective options. This medication may help control blood sugar in a different way, and researchers want to find out if it could be a helpful alternative treatment for people who have just been diagnosed.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would be randomly assigned to receive either the new continuous injection medication or standard insulin pump therapy. You would wear a small pump device under your skin for 8 weeks that continuously delivers your assigned treatment. During this time, you would have regular visits to the hospital to check your blood sugar levels, blood work, and how you're doing. After the 8-week treatment phase ends, you would return for follow-up visits over the next 12 weeks so doctors can see how well the treatment worked and how you feel after stopping it.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China